Inovio Pharmaceuticals Files 2024 10-K
Ticker: INO · Form: 10-K · Filed: Mar 18, 2025 · CIK: 1055726
| Field | Detail |
|---|---|
| Company | Inovio Pharmaceuticals, INC. (INO) |
| Form Type | 10-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
INOVIO filed its 2024 10-K. Full financials and strategy details inside.
AI Summary
Inovio Pharmaceuticals, Inc. filed its 2024 10-K on March 18, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, is based in Plymouth Meeting, PA. This filing covers its financial performance and business operations for the year, with specific financial details and disclosures to be found within the full document.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Inovio Pharmaceuticals' financial health, strategic direction, and potential risks for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Inovio faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2834 — SIC Code (Pharmaceutical Preparations industry classification.)
Key Players & Entities
- INOVIO PHARMACEUTICALS, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-18 (date) — Filing Date
- Plymouth Meeting, PA (location) — Business Address
FAQ
What was Inovio Pharmaceuticals' primary business focus during fiscal year 2024?
The filing indicates Inovio Pharmaceuticals, Inc. is in the Pharmaceutical Preparations industry (SIC 2834), suggesting a focus on drug development and related activities.
When did Inovio Pharmaceuticals file its 10-K for the fiscal year ending December 31, 2024?
The 10-K was filed on March 18, 2025.
Where is Inovio Pharmaceuticals, Inc. headquartered?
The company's business address is listed as 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462.
What is the Central Index Key (CIK) for Inovio Pharmaceuticals, Inc.?
The CIK for Inovio Pharmaceuticals, Inc. is 0001055726.
What SEC Act does this 10-K filing fall under?
This 10-K filing is made under the Securities Exchange Act of 1934.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding INOVIO PHARMACEUTICALS, INC. (INO).